FDA Drug recall D-1404-2012
Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Di…
- FDA Drug
- Class III
- terminated
- Published 2012-07-11
On 2012-07-11 the FDA classified a Class III recall of Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Di… by Mcneil Consumer Healthcare Div, citing defective Container; damaged blister units.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1404-2012 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-05-17 |
| Published | 2012-07-11 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mcneil Consumer Healthcare Div |
| Distribution | US |
Product
Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA
Reason
Defective Container; damaged blister units
Identifiers
| code_info | Lot #CMF023, Expiration 07/13. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1404-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.